- In May 2022, CONMED Corporation entered into a definitive agreement to acquire In2Bones Global, Inc., a privately-held company. In2Bones specializes in the development, manufacturing, and distribution of medical devices aimed at treating disorders and injuries of both the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. Their extensive product portfolio includes implants, fracture systems, biologics, and associated hardware
- In February 2022, DePuy Synthes, a subsidiary of Johnson & Johnson Medical Devices, acquired CrossRoads Extremity Systems, which provides a range of procedure-specific, sterile-packed implants and instruments designed for the lower extremities
Frequently Asked Questions
The market is segmented based on Global Metacarpal Joint Implants Market Segmentation By Location (Wrist, Thumb, and Hand), Ligament Type (Palmer Ligament and Collateral Ligament), End Users (Hospital And Specialty Orthopedic Clinics), Biomaterial (Metallic, Ceramic, Polymeric, and Others) – Industry Trends and Forecast to 2031
.
The Global Metacarpel Joint Implants Market size was valued at USD 1.00 USD Billion in 2023.
The Global Metacarpel Joint Implants Market is projected to grow at a CAGR of 6.6% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
